Enliven (ELVN) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Initiated Coverage | Overweight | $70.00 | Oct 2, 2026 |
| JP Morgan | Initiated Coverage | Overweight | $75.00 | Oct 1, 2026 |
| Mizuho | Maintained | Outperform | $73.00 from $62.00 | Aug 18, 2026 |
| William Blair | Initiated Coverage | Outperform | — | Aug 18, 2026 |
| Barclays | Initiated Coverage | Overweight | $78.00 | Aug 18, 2026 |
| Goldman Sachs | Maintained | Buy | $80.00 from $67.00 | Aug 6, 2026 |
| Stifel | Maintained | Buy | $82.00 from $80.00 | Aug 6, 2026 |
| Guggenheim | Maintained | Buy | $78.00 from $80.00 | Aug 6, 2026 |
| Goldman Sachs | Maintained | Buy | $67.00 from $59.00 | Jul 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $64.00 from $56.00 | Jul 9, 2026 |
| Stifel | Maintained | Buy | $80.00 from $60.00 | Jul 1, 2026 |
| Jones Trading | Maintained | Buy | $70.00 from $45.00 | Jun 29, 2026 |
| Stifel | Initiated Coverage | Buy | $60.00 | Jun 9, 2026 |
| Mizuho | Maintained | Outperform | $62.00 from $45.00 | Jun 2, 2026 |
| Goldman Sachs | Maintained | Buy | $59.00 from $41.00 | May 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $56.00 from $48.00 | Mar 26, 2026 |
| Mizuho | Maintained | Outperform | $45.00 from $41.00 | Mar 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $48.00 from $40.00 | Jul 2, 2025 |
| Baird | Maintained | Outperform | $52.00 from $40.00 | Jun 16, 2025 |
| Goldman Sachs | Initiated Coverage | Buy | $37.00 | Jun 16, 2025 |
Frequently asked questions
What is the price target for ELVN stock?
The average 12-month analyst price target for Enliven (ELVN) is $76.57, with a high estimate of $82.00 and a low of $70.00, across 7 analysts.
Is ELVN a buy, sell, or hold?
Analysts covering Enliven currently average a Buy rating: 15 buy, 0 hold and 0 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ELVN?
The average price target of $76.57 implies 94.94% upside from the last price of $39.28.
What is the latest analyst rating on ELVN?
On Oct 2, 2026, Morgan Stanley initiated coverage of Enliven at Overweight with a price target of $70.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.